Arterial Stiffness Plus Genetic Risk Dramatically Raises Heart Attack Odds
Combining high estimated pulse wave velocity with genetic predisposition multiplies coronary artery disease risk—with striking differences by race and sex.
Summary
A large US longitudinal study of 5,856 adults found that elevated estimated pulse wave velocity (ePWV ≥10 m/s), a noninvasive marker of vascular aging, raises coronary artery disease (CAD) risk by 50%. When combined with high polygenic risk score or ApoE ε4 genotype, risk patterns varied substantially by race and sex. Black participants with ApoE ε4 and high ePWV faced a 2.6-fold higher CAD risk, while White women with both high PRS and high ePWV showed a lower-than-expected risk. Cholesterol changes partially mediated the ePWV–CAD link, suggesting lipid pathways as intervention targets.
Detailed Summary
Coronary artery disease (CAD) is shaped by both biological aging processes and inherited genetic vulnerabilities. This study from Central South University (China) investigated how vascular aging—quantified by estimated pulse wave velocity (ePWV)—interacts with genetic risk factors, specifically polygenic risk scores (PRS) and apolipoprotein E (ApoE) genotypes, to determine CAD incidence in a racially and sex-diverse US population.
Researchers drew on data from the Health and Retirement Study (HRS), a nationally representative longitudinal cohort of US adults over 50. After exclusions, 5,856 participants (4,741 White, 1,115 Black) free of baseline CAD were followed biennially through 2020. ePWV was calculated from age and mean blood pressure using a validated formula, with ≥10 m/s defined as elevated. Genetic risk was captured via a lipid-related PRS and ApoE genotyping (ε2, ε3, ε4 alleles). Cox proportional hazards models assessed associations, supplemented by interaction analyses (RERI) and mediation analyses examining total cholesterol (TC) and HDL cholesterol as potential pathways.
Elevated ePWV independently predicted CAD risk (HR 1.50, 95% CI 1.25–1.81, P<0.001) in the full cohort. Among White participants, both high PRS and high ePWV independently increased CAD risk, but a statistically notable mitigating interaction was observed when both were present together—suggesting potential biological buffering or competing risk mechanisms. In Black participants, PRS was not significantly associated with CAD, reflecting known limitations of PRS derived predominantly from European ancestry GWAS data. However, Black individuals carrying the ApoE ε4 allele alongside high ePWV had a dramatically elevated CAD risk (HR 2.62, 95% CI 1.09–6.32, P=0.032). Sex-stratified analyses revealed that White women with both high PRS and high ePWV had a lower-than-expected CAD risk, possibly reflecting hormonal or physiological protective effects. Mediation analyses confirmed that changes in total cholesterol and HDL cholesterol partially mediated the ePWV–CAD association, implicating lipid metabolism as a mechanistic bridge between arterial stiffness and coronary events.
These findings have direct implications for precision cardiovascular medicine. ePWV is noninvasive and easily calculated from routine blood pressure and age data, making it a practical clinical tool. Integrating ePWV with genetic profiling—particularly ApoE genotyping in Black patients and PRS in White patients—could meaningfully refine CAD risk stratification beyond traditional risk scores. Lipid-targeted interventions may be especially beneficial for individuals with elevated ePWV.
Important caveats apply. The PRS used was developed primarily in European ancestry populations, limiting its predictive validity in Black participants. The study is observational, precluding causal inference. Self-reported CAD outcomes introduce potential misclassification, and residual confounding cannot be excluded despite extensive covariate adjustment.
Key Findings
- ePWV ≥10 m/s raised CAD risk by 50% independently of traditional cardiovascular risk factors (HR 1.50).
- Black ApoE ε4 carriers with high ePWV faced a 2.62-fold increased CAD risk—the highest subgroup risk observed.
- In White participants, high PRS and high ePWV each independently predicted CAD, but showed a potential mitigating interaction when combined.
- White women with high PRS and high ePWV had lower-than-expected CAD risk, suggesting sex-specific protective mechanisms.
- Total cholesterol and HDL cholesterol changes partially mediated the ePWV–CAD association, implicating lipid pathways.
Methodology
Longitudinal cohort study using HRS data (n=5,856; 4,741 White, 1,115 Black) with biennial follow-up through 2020. Cox proportional hazards models assessed ePWV, PRS, and ApoE genotype associations with CAD incidence, with stratified analyses by race and sex, interaction testing via RERI, and formal mediation analyses for cholesterol pathways.
Study Limitations
The PRS was derived from predominantly European ancestry GWAS, limiting applicability in Black individuals and likely explaining why PRS was not significantly associated with CAD in that subgroup. CAD outcomes relied on self-report, introducing possible misclassification bias. As an observational study, causal relationships cannot be established and residual confounding remains possible.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
